Population-based biomarker screening and the development of severe preeclampsia in California
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective To examine the relationship between second trimester maternal serum biomarkers and the development of early- and late-onset severe preeclampsia in euploid pregnancies. Study Design Included were 136,139 pregnancies participating in second trimester prenatal screening through the California Prenatal Screening Program with live births in 2006 through 2008. We identified severe preeclampsia diagnoses from hospital discharge records. We used log binomial regression to examine the association between abnormal second trimester maternal serum biomarkers and the development of severe preeclampsia. Results Approximately 0.9% of all women (n= 1,208) in our sample developed severe preeclampsia; 329 before 34 weeks gestation and 879 at or after 34 weeks. High levels of alpha fetoprotein (AFP), human gonadotropin (hCG) and inhibin (INH) (multiple of the median (MoM) ≥ 95th percentile), and low estriol (uE3) (MoM ≤ 5th percentile), were associated with severe preeclampsia (RRs 2.5 – 11.7). Biomarkers were more predictive of early-onset severe preeclampsia (RRs 3.8 – 11.7). One in 9.5 pregnancies with combined high AFP, INH and low uE3 developed severe early-onset preeclampsia compared to one in 680.5 pregnancies without any abnormal biomarkers. Conclusions The risk of developing severe preeclampsia increases for women with high second trimester AFP, hCG, INH and/or low uE3; this is especially true for early-onset severe preeclampsia. When abnormal biomarkers co-occur, risk dramatically increases. Although the screening value of second trimester biomarkers is low, abnormal biomarkers, especially when occurring in combination, appear to indicate placental dysfunction associated with the development of severe preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
Duckitt, K., & Harrington, D. (2005) · BMJ · doi:10.1136/bmj.38380.674340.e0 · Cited by 1,784
A Multivariate Analysis of Risk Factors for Preeclampsia
Eskenazi, B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470020063033 · Cited by 436
Cited by
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Baron-Cohen, S., Tsompanidis, A., Auyeung, B., Nørgaard-Pedersen, B., Hougaard, D. M., Abdallah, M., Cohen, A., & Pohl, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0454-9 · Cited by 200
Windham, G. C., Lyall, K., Anderson, M., & Kharrazi, M. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-015-2587-2 · Cited by 36
The Prenatal Hormone Milieu in Autism Spectrum Disorder
Worsham, W., Dalton, S., & Bilder, D. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.655438 · Cited by 29
Metadata
- Authors
- Taché, V., Baer, R. J., Currier, R. J., Li, C.-S., Towner, D., Waetjen, L. E., & Jelliffe-Pawlowski, L. L.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 211
- Issue
- 4
- Pages
- 377.e1-377.e8
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2087220171
- Cited by
- 32
- References
- 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.